Understanding how Dapsone works against leprosy bacteria
Mechanism of action of Dapsone in Mycobacterium leprae
This study is looking at how the antibiotic Dapsone works against the bacteria that cause leprosy, especially focusing on why some strains are resistant to the drug, which could help improve treatments for people with leprosy in the future.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Colorado State University NIH-funded |
| Lab location | 1 site (Fort Collins, United States) |
| Project ID | NIH-10914018 on NIH RePORTER |
What this research studies
This research investigates the mechanisms by which the antibiotic Dapsone affects Mycobacterium leprae, the bacteria responsible for leprosy. By comparing drug-susceptible and drug-resistant strains of the bacteria, the researchers aim to identify new molecular markers that contribute to antibiotic resistance. The study utilizes a related bacterium, Mycobacterium tuberculosis, to explore how specific genes influence resistance to Dapsone. This could lead to a better understanding of treatment failures and improve future therapies for leprosy patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with leprosy, particularly those who have experienced treatment failures.
Not a fit: Patients who do not have leprosy or those who are not affected by antibiotic resistance may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for leprosy by identifying new targets for antibiotic action.
How similar studies have performed: Previous research has shown success in identifying antibiotic resistance mechanisms in related bacteria, suggesting that this approach may yield valuable insights.
Where this research is happening
Fort Collins, United States
- Colorado State University — Fort Collins, United States (Active)
Researchers
- Principal investigator: Avanzi, Charlotte — Colorado State University
- Study coordinator: Avanzi, Charlotte
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.